Company Description
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide.
The company operates in two segments: Commercial and Wholesale, House of Brands. It cultivates, processes, and supplies medicinal-grade cannabis flower, as well as cannabis derived medical and wellness products.
The company also offers food and beverage, nutraceutical, cannabis accessories and technology, personal care, and wellness products; and cannabis consumption accessories, as well as personal storage and travel accessories for the vape and dry herbs.
In addition, it manufactures and distributes pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants.
Further, the company sells its products under the JustCBD, Vessel, and Phatebo brand names. Flora Growth Corp. was incorporated in 2019 and is headquartered in Fort Lauderdale, Florida.
| Country | United States |
| Founded | 2019 |
| IPO Date | May 11, 2021 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 75 |
| CEO | Daniel Reis-Faria |
Contact Details
Address: 3230 West. Commercial Boulevard, Suite 180 Fort Lauderdale, Florida 33309 United States | |
| Phone | 954 842 4989 |
| Website | floragrowth.com |
Stock Details
| Ticker Symbol | FLGC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 1790169 |
| CUSIP Number | 339764300 |
| ISIN Number | CA3397643006 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Reis-Faria | Chief Executive Officer and Director |
| Dany Vaiman | Chief Financial Officer |
| Michael Heinrich | Executive Chairman |
| Dr. Manfred Ziegler | Managing Director |
| Patrick Moloney | Head of Product Development |
| Aaron Atin | Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 23, 2025 | 8-K | Current Report |
| Dec 23, 2025 | SCHEDULE 13D/A | Filing |
| Dec 23, 2025 | SCHEDULE 13D/A | Filing |
| Dec 23, 2025 | SCHEDULE 13D/A | Filing |
| Dec 23, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Dec 22, 2025 | 8-K | Current Report |
| Dec 10, 2025 | EFFECT | Notice of Effectiveness |
| Nov 28, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Nov 28, 2025 | 8-K | Current Report |
| Nov 18, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |